How to Source Non-IMP Supplies for Clinical Trials
Tim Holmes, Manager, Clinical Oversight of Supplies, Biogen, offers considerations on how to obtain non-IMP...
Read More...
Focus:
-
![]()
How Whole Systems Thinking Could Transform the Clinical Supply Chain
Hedley Rees, Chief Disruptor, PharmaFlow, discusses the need for a rethink on supply chain processes
Read More...
-
![]()
Managing Blinding Requirements in IRT: An Overview
Francesco Spoto, Clinical Project Manager, explores the opportunities of using IRT solutions to manage blinded...
Read More...
-
![]()
Industry Viewpoints: Clinical Trials in Asia – Key Considerations
Mainfong Ang, Amgen, sits down with CTA’s Jisong Seo about the difficulties of clinical operations...
Read More...
-
![]()
Integrating New Assets: A Supply Chain Perspective
Barrett Glasser, Associate Director, Clinical Drug Supply, Biogen, provides an overview on how to on...
Read More...
-
![]()
Strategic Comparator Sourcing – A Matter of High Priority
Ian Hoban, Pilatus Comparator Solutions, poses some key questions that should be front of mind...
Read More...
-
![]()
The Dawn of Cell Therapies, Blockchain, and M&A: Industry Trends in the CMO Landscape
Peter Shapiro, Editor-In-Chief, PharmSource, a GlobalData Product, assesses key trends currently changing the face of...
Read More...
-
![]()
Global Standards for Identification: Untapped Opportunities in the Clinical Trial Supply Chain
Jesper Franke, Head of Healthcare, GS1 Denmark, explains how the industry can best improve supply...
Read More...
-
![]()
Elucidating Opportunities for Cost Reduction of Clinical Trials Through Supply Management Optimization
Anthony Zuccarello, Associate Director, IRT and Global Clinical Supply Strategy, Amicus Therapeutics, offers insight on...
Read More...
-
![]()
Industry Viewpoints: Digitizing Clinical Manufacturing
Clive E. Badman, OBE, talks to CTA’s Charlie Abrines about the digitization of the clinical...
Read More...
